Central action of 11-(3-dimethylaminopropylidene)-6,11-dihydro-dibenzo-(b,e)oxepine hydrocholoride (doxepine).
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000378:metabolism*; D003342:Corpus Striatum / Q000378:metabolism; D004316:Doxepin / Q000494:pharmacology*; D004336:Drug Antagonism; D006834:Hydrazines / Q000494:pharmacology; D007031:Hypothalamus / Q000378:metabolism; D066298:In Vitro Techniques; D008297:Male; D008526:Medulla Oblongata / Q000378:metabolism; D008636:Mesencephalon / Q000378:metabolism; D051379:Mice; D008815:Mice, Inbred Strains; D009043:Motor Activity / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism*; D011149:Pons / Q000378:metabolism; D011807:Quinolizines / Q000494:pharmacology; D051381:Rats; D013997:Time Factors; D014316:Tritium
D006834:Hydrazines; D011807:Quinolizines; D014316:Tritium; D004316:Doxepin; D000661:Amphetamine; D009638:Norepinephrine